retatrutide phase2 weight loss is investigational and is not FDA approved. In TRANSCEND-T2D-1, investigators randomized 537 adults with type 2 diabetes inadequately controlled by diet and exercise in a 40-week, double-blind, placebo-controlled phase 3 trial Retatrutide Delivers Significant Hemoglobin A1C

480 GiloteauxLO'NealACastro-MarreroJLevineSMHansonMR

This makes adhering to the treatment plan simpler and increases the compliance of patients who are taking care of their diabetes, providing a sustained therapeutic effect with fewer doses

Fine lines around my eyes are softer already

When insulin resistance or high androgens interfere, ovulation can become irregular or stop completely

The molecular and structural/functional changes translate to (1) Tubular atrophy, podocyte hypertrophy, glomerulosclerosis, and microvascular rarefaction and (2) glomerular basement membrane thickening, nephrosclerosis, and extracellular matrix accumulation, respectively [84]